title: Seroprevalence and epidemiologic correlates of human immunodeficiency virus infection in women with acute pelvic inflammatory disease.
abstract: As the number of women with acquired immunodeficiency syndrome (AIDS) continues to rise in the United States, it becomes important to target preventive interventions as effectively as possible toward those groups at highest risk of acquiring human immunodeficiency virus (HIV) infection. We analyzed the prevalence of serum antibody to HIV in 333 women admitted to the Gynecology Service at San Francisco General Hospital with acute pelvic inflammatory disease in the years 1985-1988. The proportion of women with HIV infection in our sample rose incrementally over this 4-year period, from 0 to 6.7%. A history of intravenous (IV) drug use conferred a 23-fold risk of HIV seropositivity. In contrast, markers of the level of sexual activity did not correlate significantly with the presence of HIV infection, although the power to detect such an association was limited by the small sample size. An intensification of educational efforts directed at IV drug-using women in San Francisco is necessary to prevent further increases in the rate of HIV infection and further spread into the heterosexual population.
authors.affiliation: Department of Medicine, University of California, San Francisco.
authors.forename: S
authors.initials: S
authors.lastname: Safrin
authors.forename: B J
authors.initials: BJ
authors.lastname: Dattel
authors.forename: L
authors.initials: L
authors.lastname: Hauer
authors.forename: R L
authors.initials: RL
authors.lastname: Sweet
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000453:epidemiology; D000208:Acute Disease; D000328:Adult; D005260:Female; D015528:HIV Seroprevalence; D006801:Humans; D000292:Pelvic Inflammatory Disease / Q000150:complications* / Q000276:immunology; D012307:Risk Factors; D012495:San Francisco / Q000453:epidemiology; D011477:Sex Work; D012725:Sexual Behavior; D015231:Sexually Transmitted Diseases, Bacterial / Q000150:complications; D015819:Substance Abuse, Intravenous / Q000150:complications